Biotech · Private company · Greenville, SC, US
Zylo Therapeutics, Inc.
Track this companyFree. Adds Zylo Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Development and optimization of a nitric oxide releasing microparticle formulation for the topical treatment of chronic rhinosinusitisFiscal year 2026 · $300KNIH RePORTER 5R41AI188793-02 · fetched Nov 12, 2026
- Development and optimization of a nitric oxide releasing microparticle formulation for the topical treatment of chronic rhinosinusitisFiscal year 2025 · $300KNIH RePORTER 1R41AI188793-01A1 · fetched Nov 12, 2026
- Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.Fiscal year 2024 · $145.9KNIH RePORTER 5R41AR082749-02 · fetched Nov 12, 2026